Clinical Trial Update: PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating PSMA-PET/MRI for radiation treatment planning in locally metastatic prostate cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Metastatic Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-04-26